4D Molecular Therapeutics, Inc. (FDMT) vs OmniAb, Inc. (OABI)
A side-by-side comparison of 4D Molecular Therapeutics, Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FDMT
4D Molecular Therapeutics, Inc.
$12.73HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
OABI
OmniAb, Inc.
$4.48HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — FDMT vs OABI
growth of $100 · dividends reinvested · last 5yFDMT -53.7% (-14.3%/yr)OABI -49.6% (-12.8%/yr)OABI compounded faster over this window
FDMT OABI
FDMT vs OABI: by the numbers
- •FDMT is the larger company ($666M vs $649M market cap).
- •Both run net losses; OABI's is the smaller (-115.18% vs -194.74% net margin).
- •FDMT grew revenue faster over the past five years (31.93% vs -4.31% CAGR).
Metrics side by side
Valuation
| Metric | FDMT | OABI |
|---|---|---|
| P/S ratio | 7.23 | 16.90 |
| P/B ratio | 1.63 | 2.50 |
Profitability
| Metric | FDMT | OABI |
|---|---|---|
| Gross margin | 91.05% | -18.17% |
| Operating margin | -187.24% | -383.15% |
| Net margin | -194.74% | -115.18% |
| ROE | -43.95% | -17.01% |
| ROIC | -44.30% | -17.48% |
Growth (annualized)
| Metric | FDMT | OABI |
|---|---|---|
| Revenue CAGR (5Y) | 31.93% | -4.31% |
| Total return CAGR (5Y) | -13.08% | -13.17% |
Frequently asked
- Which has grown faster, FDMT or OABI?
- Over the past five years, FDMT grew revenue faster — FDMT at a 31.93% CAGR versus OABI at -4.31%.
Go deeper
Dig into the metrics
4D Molecular Therapeutics ROEOmniAb ROE4D Molecular Therapeutics operating marginOmniAb operating margin4D Molecular Therapeutics revenue growthOmniAb revenue growth4D Molecular Therapeutics free cash flowOmniAb free cash flow
4D Molecular Therapeutics & OmniAb appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.